176 related articles for article (PubMed ID: 22766189)
1. New developments in erythropoietic porphyrias.
Darwich E; Herrero C
Actas Dermosifiliogr; 2013 Apr; 104(3):212-9. PubMed ID: 22766189
[TBL] [Abstract][Full Text] [Related]
2. Congenital erythropoietic porphyria and erythropoietic protoporphyria: Identification of 7 uroporphyrinogen III synthase and 20 ferrochelatase novel mutations.
Weiss Y; Balwani M; Chen B; Yasuda M; Nazarenko I; Desnick RJ
Mol Genet Metab; 2019 Nov; 128(3):358-362. PubMed ID: 30454868
[TBL] [Abstract][Full Text] [Related]
3. ALAS2 acts as a modifier gene in patients with congenital erythropoietic porphyria.
To-Figueras J; Ducamp S; Clayton J; Badenas C; Delaby C; Ged C; Lyoumi S; Gouya L; de Verneuil H; Beaumont C; Ferreira GC; Deybach JC; Herrero C; Puy H
Blood; 2011 Aug; 118(6):1443-51. PubMed ID: 21653323
[TBL] [Abstract][Full Text] [Related]
4. Advances in understanding the pathogenesis of congenital erythropoietic porphyria.
Di Pierro E; Brancaleoni V; Granata F
Br J Haematol; 2016 May; 173(3):365-79. PubMed ID: 26969896
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of porphyrias in Italy: a diagnostic flow-chart.
Martinez di Montemuros F; Di Pierro E; Patti E; Tavazzi D; Danielli MG; Biolcati G; Rocchi E; Cappellini MD
Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):867-76. PubMed ID: 12699245
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietic porphyrias: animal models and update in gene-based therapies.
Richard E; Robert-Richard E; Ged C; Moreau-Gaudry F; de Verneuil H
Curr Gene Ther; 2008 Jun; 8(3):176-86. PubMed ID: 18537592
[TBL] [Abstract][Full Text] [Related]
7. Hematologic aspects of the porphyrias.
Sassa S
Int J Hematol; 2000 Jan; 71(1):1-17. PubMed ID: 10729988
[TBL] [Abstract][Full Text] [Related]
8. A genotype-phenotype correlation between null-allele mutations in the ferrochelatase gene and liver complication in patients with erythropoietic protoporphyria.
Minder EI; Gouya L; Schneider-Yin X; Deybach JC
Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):91-6. PubMed ID: 11929053
[TBL] [Abstract][Full Text] [Related]
9. Late-onset erythropoietic porphyria caused by a chromosome 18q deletion in erythroid cells.
Aplin C; Whatley SD; Thompson P; Hoy T; Fisher P; Singer C; Lovell CR; Elder GH
J Invest Dermatol; 2001 Dec; 117(6):1647-9. PubMed ID: 11886534
[TBL] [Abstract][Full Text] [Related]
10. Recent advances on porphyria genetics: Inheritance, penetrance & molecular heterogeneity, including new modifying/causative genes.
Yasuda M; Chen B; Desnick RJ
Mol Genet Metab; 2019 Nov; 128(3):320-331. PubMed ID: 30594473
[TBL] [Abstract][Full Text] [Related]
11. [Successful gene therapy of mice with congenital erythropoietic porphyria].
de Verneuil H; Robert-Richard E; Ged C; Mazurier F; Richard E; Moreau-Gaudry F
Med Sci (Paris); 2008; 24(6-7):615-20. PubMed ID: 18601879
[TBL] [Abstract][Full Text] [Related]
12. Congenital erythropoietic porphyria: mutation update and correlations between genotype and phenotype.
Ged C; Moreau-Gaudry F; Richard E; Robert-Richard E; de Verneuil H
Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):53-60. PubMed ID: 19268002
[TBL] [Abstract][Full Text] [Related]
13. A molecular study of congenital erythropoietic porphyria in cattle.
Agerholm JS; Thulstrup PW; Bjerrum MJ; Bendixen C; Jørgensen CB; Fredholm M
Anim Genet; 2012 Apr; 43(2):210-5. PubMed ID: 22404357
[TBL] [Abstract][Full Text] [Related]
14. Congenital erythropoietic porphyria: a single-observer clinical study of 29 cases.
Katugampola RP; Badminton MN; Finlay AY; Whatley S; Woolf J; Mason N; Deybach JC; Puy H; Ged C; de Verneuil H; Hanneken S; Minder E; Schneider-Yin X; Anstey AV
Br J Dermatol; 2012 Oct; 167(4):901-13. PubMed ID: 22816431
[TBL] [Abstract][Full Text] [Related]
15. The porphyrias: advances in diagnosis and treatment.
Balwani M; Desnick RJ
Hematology Am Soc Hematol Educ Program; 2012; 2012():19-27. PubMed ID: 23233556
[TBL] [Abstract][Full Text] [Related]
16. [Congenital erythropoietic porphyria].
Tanigawa K; Takamura N; Yamashita S
Nihon Rinsho; 1995 Jun; 53(6):1422-6. PubMed ID: 7616657
[TBL] [Abstract][Full Text] [Related]
17. Porphyria in Switzerland, 15 years experience.
Schneider-Yin X; Harms J; Minder EI
Swiss Med Wkly; 2009 Apr; 139(13-14):198-206. PubMed ID: 19350426
[TBL] [Abstract][Full Text] [Related]
18. Molecular genetics of congenital erythropoietic porphyria.
Desnick RJ; Glass IA; Xu W; Solis C; Astrin KH
Semin Liver Dis; 1998; 18(1):77-84. PubMed ID: 9516681
[TBL] [Abstract][Full Text] [Related]
19. Congenital erythropoietic porphyria: prolonged high-level expression and correction of the heme biosynthetic defect by retroviral-mediated gene transfer into porphyric and erythroid cells.
Kauppinen R; Glass IA; Aizencang G; Astrin KH; Atweh GF; Desnick RJ
Mol Genet Metab; 1998 Sep; 65(1):10-7. PubMed ID: 9787090
[TBL] [Abstract][Full Text] [Related]
20. Missense UROS mutations causing congenital erythropoietic porphyria reduce UROS homeostasis that can be rescued by proteasome inhibition.
Blouin JM; Bernardo-Seisdedos G; Sasso E; Esteve J; Ged C; Lalanne M; Sanz-Parra A; Urquiza P; de Verneuil H; Millet O; Richard E
Hum Mol Genet; 2017 Apr; 26(8):1565-1576. PubMed ID: 28334762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
